Highly focalised thermotherapy using a ferrimagnetic cement in the treatment of a melanoma mouse model by low temperature hyperthermia

References

• Lee CT, Mace T, Repasky EA. Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer?. Int J Hyperthermia 2010; 26: 232–246
   PubMed Web of Science ®Google Scholar
• Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia 2006; 22: 197–203
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and the molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56
   PubMed Web of Science ®Google Scholar
• Pappeti M, Herman I. Mechanism of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002; 282: c947–c970
   Web of Science ®Google Scholar
• Sakaguchi Y, Stephens LC, Makino M, Kaneko T, Strebel FR, Danhauser LL, et al. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats. Cancer Res 1995; 55: 5459–5464
   PubMed Web of Science ®Google Scholar
• Vaupel PW, Kelleher DK. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue. Int J Hyperthermia 2010; 26: 211–223
   PubMed Web of Science ®Google Scholar
• Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999; 201: 413–419
   Web of Science ®Google Scholar
• Sakuray H, Kitamoto Y, Saitoh J, Nonaka T, Ishikawa H, Kiyohara H, et al. Attenuation of chronic thermotolerance by KNK437, a benzylidene lactam compound, enhances thermal radiosensitization in mild temperature hyperthermia combined with low dose-rate irradiation. Int J Radiat Biol 2005; 81: 711–718
   PubMed Web of Science ®Google Scholar
• Armour EP, McEachern D, Wang Z, Corry PM, Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Res 1993; 53: 2740–2744
   PubMed Web of Science ®Google Scholar
• Mackey MA, Anolik SL, Roti Roti JL. Cellular mechanisms associated with the lack of chronic thermotolerance expression in HeLa S3 cells. Cancer Res 1992; 52: 1101–1106
   PubMed Web of Science ®Google Scholar
• Ryu S, Brown SL, Kim SH, Khil MS, Kim JH. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996; 34: 133–138
   PubMed Web of Science ®Google Scholar
• Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1996; 12: 367–373
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000; 60: 6950–6957
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002; 18: 563–575
   PubMed Web of Science ®Google Scholar
• O’Neill KL, Fairbairn DW, Smith MJ, Poe BS. Critical parameters influencing hyperthermia-induced apoptosis in human lymphoid cell lines. Apoptosis 1998; 3: 369–375
   PubMed Web of Science ®Google Scholar
• Field SB. Physics and technology of hyperthermia. NATO ASI series, E: Applied Sciences, SB Field, C Franconi. Martinus Nijhoff, Dordrecht 1987; 19–27
   Google Scholar
• Szasz A. Hyperthermia, a modality in the wings. J Cancer Res Ther 2007; 3: 56–66
   PubMedGoogle Scholar
• Moroz P, Jones SK, Gray BN. Magnetically mediated hyperthermia: Current status and future directions. Int J Hyperthermia 2002; 18: 267–284
   PubMed Web of Science ®Google Scholar
• van der Zee J. Heating the patient: A promising approach?. Ann Oncol 2002; 13: 1173–1184
   PubMed Web of Science ®Google Scholar
• Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008; 24: 251–261
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Scholz R, Tesch B, Fähling H, Mitrovics T, et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia 1996; 12: 705–722
   PubMed Web of Science ®Google Scholar
• Sato K, Watanabe Y, Horiuchi A, Yukumi S, Doi T, Yoshida M, et al. Feasibility of new heating method of hepatic parenchyma using a sintered MgFe2O4 needle under an alternating magnetic field. J Surg Res 2008; 146: 110–116
   PubMed Web of Science ®Google Scholar
• Suzuki M, Shinkai M, Honda H, Kobayashi T. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 2003; 13: 129–135
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferromagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 2009; 25: 499–511
   PubMed Web of Science ®Google Scholar
• Jones SK, Winter JG. Experimental examination of a targeted hyperthermia system using inductively heated ferromagnetic microspheres in rabbit kidney. Phys Med Biol 2001; 46: 385–398
   PubMed Web of Science ®Google Scholar
• Kawashita M, Tanaka M, Kokubo T, Inoue Y, Yao T, Hamada S, et al. Preparation of ferrimagnetic microspheres for in situ hyperthermic treatment of cancer. Biomaterials 2005; 26: 2231–2238
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9: 51–68
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldofner N, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 2005; 64: 283–292
   PubMed Web of Science ®Google Scholar
• Schneider S, Rusconi S. Magnetic selection of transiently transfected cells. Biotechniques 1996; 21: 876–880
   PubMed Web of Science ®Google Scholar
• Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: An in vivo study. Jpn J Cancer Res 1998; 89: 463–469
   PubMedGoogle Scholar
• Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposome: In vitro study. Jpn J Cancer Res 1996; 87: 1179–1183
   PubMedGoogle Scholar
• Ohno T, Wakabayashi T, Takemura A, Yoshida J, Ito A, Shinkai M, et al. Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study. J Neurooncol 2002; 56: 233–239
   PubMed Web of Science ®Google Scholar
• Saito H, Mitobe K, Ito A, Sugawara Y, Maruyama K, Minamiya Y, et al. Self-regulating hyperthermia induced using thermosensitive ferromagnetic material with low Curie temperature. Cancer Sci 2008; 99: 805–809
   PubMed Web of Science ®Google Scholar
• Kokubo T. Bioactive glass ceramics: Properties and applications. Biomaterials 1991; 12: 155–163
   PubMed Web of Science ®Google Scholar
• Matsumine A, Takegami K, Asanuma K, Matsubara T, Nakamura T, Uchida A, et al. A novel hyperthermia treatment for bone metastases using magnetic materials. Int J Clin Oncol 2011; 16: 101–108
   PubMed Web of Science ®Google Scholar
• Jiang Y, Ou J, Zhang Z, Qin Q. Preparation of magnetic and bioactive calcium zinc iron silicon oxide composite for hyperthermia treatment of bone cancer and repair of bone defects. J Mater Sci Mater Med 2011; 22: 721–729
   PubMed Web of Science ®Google Scholar
• Kawashita M, Kawamura K, Li Z. PMMA-based bone cements containing magnetite particles for the hyperthermia of cancer. Acta Biomaterialia 2010; 6: 3187–3192
   PubMed Web of Science ®Google Scholar
• Portela A, Vasconcelos M, Branco R, Gartner F, Faria M, Cavalheiro J. An in vitro and in vivo investigation of the biological behaviour of a ferrimagnetic cement for highly focalised thermotherapy. J Mat Sci Mat Med 2010; 1: 2413–2423
   Google Scholar
• Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: An in vivo study. Jpn J Cancer Res 1998; 89: 463–469
   PubMedGoogle Scholar
• Norma Portuguesa. Avaliação biológica dos dispositivos médicos, Parte 2: Requisitos para o bem estar dos animais [Biological evaluation of medical devices, Part 2: Animal Welfare Requirements]. 2000, NP EN ISO 10993–2
   Google Scholar
• Buhtoiarov IN, Lum HE, Berke G, Sondel PM, Rakhmilevich AL. Synergistic activation of macrophages via CD40 and TLR9 results in T cells independent anti-tumor effects. J Immunol 2006; 176: 308–318
   Web of Science ®Google Scholar
• Bancroft JD, Gamble M. Theory and Practice of Histological Techniques6th. Churchill Livingstone, New York 2007
   Google Scholar
• Tucker RD, Loening SA, Landas S, Paulus JA, Ren ZY, Park JB. The effect of interstitial hyperthermia on the Dunning prostate tumor model. J Urol 1992; 147: 1129–1133
   PubMed Web of Science ®Google Scholar
• Dings RPM, Loren ML, Zhang Y, Mikkelson S, Mayo KH, Corry P, et al. Tumour thermotolerance, a physiological phenomenon involving vessels normalisation. Int J Hyperthermia 2011; 27: 42–52
   PubMed Web of Science ®Google Scholar
• Cesta MF. Normal structure, function, and histology of the spleen. Toxicol Pathol 2006; 34: 455–465
   PubMed Web of Science ®Google Scholar
• Balivada S, Rachakatla RS, Wang H, Samarakoon TN, Dani RK, Pyle M, et al. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: A mouse study. BMC Cancer 2010; 10: 119
   PubMed Web of Science ®Google Scholar
• Ito A, Fujioka M, Yoshida T, Wakamatsu K, Ito S, Yamashita T, et al. 4-S-cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci 2007; 98: 424–430
   PubMed Web of Science ®Google Scholar
• Ito A, Saito H, Mitobe K, Minamiya Y, Takahashi N, Maruyama K, et al. Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature. Cancer Sci 2009; 100: 558–564
   PubMed Web of Science ®Google Scholar
• Krysko D, Berghe TV, D’Herde K, Vandenabeele P. Apoptosis and necrosis: Detection, discrimination and phagocytosis. Methods 2008; 44: 205–221
   PubMed Web of Science ®Google Scholar
• Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257
   PubMed Web of Science ®Google Scholar
• Green DR. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 2000; 102: 1–4
   PubMed Web of Science ®Google Scholar
• Garcia MP, Cavalheiro J, Fernandes MH. Acute and long-term effects of hyperthermia in B16-F10 melanoma cells. PLoS ONE 2012; 7: e35489, doi:10.1371/journal.pone.0035489
   PubMed Web of Science ®Google Scholar
• Ito A, Matsuoka F, Honda H, Kobayashi T. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother 2004; 53: 26–32
   PubMed Web of Science ®Google Scholar
• Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 2003; 94: 308–313
   PubMed Web of Science ®Google Scholar